Doctors seek best chemo for aggressive breast cancer
Disease control
Terminated
This study aimed to compare three standard chemotherapy treatments for triple-negative breast cancer, an aggressive form that doesn't respond to hormone therapies. Researchers wanted to test a new consent approach while determining which chemotherapy regimen works best for patien…
Phase: PHASE4 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC